Brief: Appili Therapeutics Reports Financial And Operational Results For Second Quarter Of Fiscal Year 2022 And Change Of Chief Financial Officer
Nov 12 (Reuters) - Appili Therapeutics Inc APLI.TO :
* APPILI THERAPEUTICS REPORTS FINANCIAL AND OPERATIONAL
RESULTS
FOR SECOND QUARTER OF FISCAL YEAR 2022 AND CHANGE OF CHIEF
FINANCIAL OFFICER
* APPILI THERAPEUTICS INC - KENNETH G. HOWLING WILL BE
JOINING
APPILI THERAPEUTICS AS ACTING CHIEF FINANCIAL OFFICER THIS FALL
* APPILI THERAPEUTICS INC - KIMBERLY STEPHENS, CO'S CFO HAS
CHOSEN TO LEAVE APPILI FOR PERSONAL REASONS EFFECTIVE NOVEMBER
16, 2021
Source text for Eikon: ID:nBw9xg5Ksa
Further company coverage: APLI.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Appili Therapeutics
See all newsBrief: Appili Therapeutics Announces Closing Of Second Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Closes First Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Formal Termination Of Arrangement Agreement With Aditxt
Brief: Appili Therapeutics Announces New Patents Granted For Commercial Stage Asset Likmez